Noticias de JAGX_US

Noticias del mercado

Últimas noticias sobre JAGX_US — 356 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: JAGX_US ✕ 356 resultados
08/04/2026 JAGX_US — Stock Titan
Dog cancer-treatment diarrhea drug nears FDA filing after trial
08/04/2026 JAGX_US — ACCESS Newswire
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
08/04/2026 JAGX_US — Investing.com
Jaguar Health completes diarrhea study in dogs on chemo
08/04/2026 JAGX_US — GuruFocus
Jaguar Health (JAGX) Advances Canalevia-CA1 Study for Chemothera
08/04/2026 JAGX_US — Yahoo Finance
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
07/04/2026 JAGX_US — GuruFocus
JAGX Sees Slight Revenue Decline Amid Decrease in Mytesi Prescri
07/04/2026 JAGX_US — ACCESS Newswire
Jaguar Health Reports 2025 Financials
07/04/2026 JAGX_US — Yahoo Finance
Jaguar Health Reports 2025 Financials
07/04/2026 JAGX_US — Stock Titan
Jaguar lands $16M license payment as Nasdaq delisting is stayed
07/04/2026 JAGX_US — Stock Titan
Wider 2025 loss, $16M Future Pak deal and Nasdaq risk for Jaguar Health (JAGX)
07/04/2026 JAGX_US — Stock Titan
Jaguar Health (NASDAQ: JAGX) leans into rare GI drugs and $16M Mytesi deal
07/04/2026 JAGX_US — Minichart
Jaguar Health Reports 2025 Financial Results: 5% Q4 Revenue Growth, $16M Up-Front License Deal, and Nasdaq Compliance Appeal 1
07/04/2026 JAGX_US — MarketScreener ES ← EN
Informes de salud de Jaguar Finanzas 2025
07/04/2026 JAGX_US — TradingView
Jaguar Health 2025 10-K: $11.51M Revenue, ($22.97) EPS
07/04/2026 JAGX_US — MarketScreener
Jaguar Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
06/04/2026 JAGX_US — vinhcong.tayninh.gov.vn
Is Jaguar Health (JAGX) Stock Undervalued Now | Price at $0.41, Up 1.75% - Capital Preservation
06/04/2026 JAGX_US — MarketScreener
Jaguar Health, Inc. Auditor Raises 'Going Concern' Doubt
06/04/2026 JAGX_US — tayninh.gov.vn
Is Jaguar Health (JAGX) Stock Undervalued Now | Price at $0.41, Up 1.75% - Capital Preservation
06/04/2026 JAGX_US — sonla.gov.vn
Is Jaguar Health (JAGX) Stock Undervalued Now | Price at $0.41, Up 1.75% - Capital Preservation
06/04/2026 JAGX_US — haiphong.gov.vn ES ← EN
¿Están infravaloradas ahora las acciones de Jaguar Health (JAGX)? Precio a 0,41 dólares, aumento del 1,75 % - Preservación de capital

Página 17 de 18

keyboard_arrow_up